Paper Details

  1. Home
  2. Paper Details

Oritavancin, a single-dose, complete regimen, for the treatment of acute bacterial skin and skin structure infections.

Author: AbrahamTeena, ElnadouryOla, KuanWilliam, LeeSpencer, LiuMei, TruongJames, WuAnh, WuGary

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Oritavancin, a lipoglycopeptide antibiotic, is approved for treating adult patients with acute bacterial skin and skin structure infections (ABSSSI). Unlike other intravenous antibiotics, it offers a single-dose complete regimen, eliminating the need for an indwelling catheter and potentially avoiding hospital admission. This availability provides another treatment option for ABSSSI caused by susceptible bacteria.
Paper Details　
Original Abstract of the Article :
Oritavancin, a lipoglycopeptide antibiotic, recently received US FDA approval for the treatment of adult patients with acute bacterial skin and skin structure infections (ABSSSI). Oritavancin, unlike other intravenous antibiotics that are currently available for the treatment of ABSSSI (e.g., vancom...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1586/14787210.2015.1012498

データ提供：米国国立医学図書館（NLM）

Oritavancin: A Single-Dose Solution for Skin Infections

The search for more effective and convenient treatments for bacterial infections is a constant endeavor. This research explores the potential of oritavancin, a novel lipoglycopeptide antibiotic, for treating acute bacterial skin and skin structure infections (ABSSSI). It's like finding a new weapon in the arsenal against bacterial infections, potentially offering a more efficient and convenient approach to treatment.

Oritavancin: A Promising New Antibiotic

The study highlights the potential of oritavancin as a single-dose treatment option for ABSSSI, offering a significant advantage over traditional antibiotic regimens. It's like discovering a hidden oasis of convenience within the desert of antibiotic treatments. This innovative approach could streamline treatment, potentially reducing hospital stays and improving patient outcomes.

A New Era in Skin Infection Treatment

This research underscores the potential of oritavancin to revolutionize the treatment of ABSSSI. It's like finding a new path through the desert of skin infection treatments, offering a more efficient and potentially more effective approach. Further research is needed to fully evaluate the long-term effectiveness and safety of oritavancin, but the findings suggest a promising future for this innovative antibiotic.

Dr. Camel's Conclusion

This research delves into the potential of oritavancin, a new antibiotic, for treating skin infections. It's like discovering a hidden oasis of convenience and effectiveness within the desert of antibiotic treatments. Oritavancin could potentially transform the approach to managing skin infections, offering a more efficient and potentially more effective treatment option.

Date :
  1. Date Completed 2015-11-23
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25661747

DOI: Digital Object Identifier

10.1586/14787210.2015.1012498

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.